Literature DB >> 7105489

Immunochemical features of a case of progressive rubella panencephalitis.

J S Wolinsky, M N Waxham, J L Hess, J J Townsend, J R Baringer.   

Abstract

Progressive rubella panencephalitis (PRP), a slowly progressive and fatal central nervous system (CNS) disorder due to rubella virus, is characterized by high cerebrospinal fluid (CSF) levels of immunoglobulins, oligoclonal bands and high CSF:serum rubella antibody titre ratios. Sera, CSF and neutral extracts of brain, spleen, lymph node and kidney obtained at autopsy from a case were analysed for immunoglobulin isotype and content by enzyme linked immunosorbent assays. Comparable titres of rubella specific IgA and IgG were found in sera and CSF, but accounted for a disproportionate amount of the isotype specific immunoglobulins of CSF (0.19%, 14.0%) as compared to serum (0.02%, 0.69%). The percentage of isotype specific immunoglobulins were not increased in extracts of most visceral tissues compared to serum, however, rubella specific IgA and IgG were disproportionately increased in extracts from most regions of brain sampled (1-60-fold and 8-27-fold respectively). No rubella specific IgM could be conclusively demonstrated in any specimen. Immunoprecipitation studies showed that the IgG reacted with the major glycoproteins (gp62, gp47-56 complex) and non-glycosylated polypeptide (p38) of radiolabelled rubella virions and infected cell lysates. These studies support the conclusion that a major portion of the rubella specific antibody is produced within the CNS of patients with PRP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105489      PMCID: PMC1536479     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  [Rubella virus. I. Morphology and structural proteins].

Authors:  P Payment; D Ajdukovic; V Pavilanis
Journal:  Can J Microbiol       Date:  1975-05       Impact factor: 2.419

2.  Intrathecal Rubella and RNA antibody synthesis in multiple sclerosis and progressive rubella panencephalitis.

Authors:  E Schuller; N Delasnerie; B Allinquant; P Lebon
Journal:  Biomedicine       Date:  1977-06

3.  Detection of viral proteins in mouse mammary tumors by immunoperoxidase staining of paraffin sections.

Authors:  I Keydar; R Mesa-Tejada; M Ramanarayanan; T Ohno; C Fenoglio; R Hu; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  Progressive rubella panencephalitis.

Authors:  J S Wolinsky; B O Berg; C H Maitalnd
Journal:  Arch Neurol       Date:  1976-10

5.  Quantitation of measles virus-specific immunoglobulins in serum, CSF, and brain extract from patients with subactue sclerosing panencephalitis.

Authors:  P D Mehta; A Kane; H Thormar
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

Review 6.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

7.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

8.  Progressive rubella virus panencephalitis: synthesis of oligoclonal virus-specific IgG antibodies and homogeneous free light chains in the central nervous system.

Authors:  B Vandvik; M L Weil; M Grandien; E Norrby
Journal:  Acta Neurol Scand       Date:  1978-01       Impact factor: 3.209

9.  Structural proteins and subunits of rubella virus.

Authors:  A Vaheri; T Hovi
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

10.  Isolation of rubella virus from brain in chronic progressive panencephalitis.

Authors:  N E Cremer; L S Oshiro; M L Weil; E H Lennette; H H Itabashi; L Carnay
Journal:  J Gen Virol       Date:  1975-11       Impact factor: 3.891

View more
  5 in total

1.  Effect of antiviral antibody on maintenance of long-term rubella virus persistent infection in Vero cells.

Authors:  E S Abernathy; C Y Wang; T K Frey
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.

Authors:  J S Wolinsky; M N Waxham; A C Server
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  Antibody response to individual rubella virus proteins in congenital and other rubella virus infections.

Authors:  S Katow; A Sugiura
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

Review 4.  Does Rubella Cause Autism: A 2015 Reappraisal?

Authors:  Jill Hutton
Journal:  Front Hum Neurosci       Date:  2016-02-01       Impact factor: 3.169

5.  Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.

Authors:  Ludmila Perelygina; Timo Hautala; Mikko Seppänen; Adebola Adebayo; Kathleen E Sullivan; Joseph Icenogle
Journal:  Antiviral Res       Date:  2017-09-30       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.